Loading ...
Sorry, an error occurred while loading the content.
 

[HEALTH] Researcher Behind PSA Test Sees Promise

Expand Messages
  • chiayuan25
    Researcher Behind PSA Test Sees Promise By CAROLYN THOMPSON, Associated Press Writer Thu Aug 4, 9:51 PM ET BUFFALO, N.Y. - Prostate cancer was almost always a
    Message 1 of 1 , Aug 5, 2005
      Researcher Behind PSA Test Sees Promise
      By CAROLYN THOMPSON, Associated Press Writer
      Thu Aug 4, 9:51 PM ET

      BUFFALO, N.Y. - Prostate cancer was almost always a death sentence
      when Dr. T. Ming Chu made it his life's work to find a way to detect
      it early on. Now, survival is the norm, in part, many say, because
      Chu accomplished his goal.

      The Roswell Park Cancer Institute researcher is responsible for the
      widely used PSA test that diagnoses prostate cancer by measuring a
      protein the prostate makes when it's inflamed.

      "From the start that was our goal," said Chu, reflecting recently on
      the 25th anniversary of his discovery.

      A humble Chu said his work has been gratifying. The head of Roswell
      Park's Urologic Oncology Department described it as revolutionary,
      and the primary reason for the disease's declining death rate.

      "This has changed entirely the field of prostate cancer," Dr. James
      Mohler said, "both its potential cure as well as our ability to
      monitor the disease and test novel therapies for those men we cannot
      cure."

      Although he is retired, Chu looks forward to the day when colleagues
      who continue his work at the Buffalo hospital and elsewhere improve
      upon the test, which — despite its use around the world — is
      controversial.

      The American Cancer Society advises testing be offered to most
      men 50 and older, but the federal Centers for Disease Control stops
      short of recommending it amid concerns about false positives and
      questions about whether early detection actually saves lives.

      "I would be the first one to say PSA is not a perfect test," said
      Chu, who was born in Taiwan and spent his career in Buffalo after
      receiving a Ph.D in biochemistry from Pennsylvania State University
      in 1967. "It's not perfect, but it's the best we have."

      And continuing research, he and others said, holds much promise.

      A study published last year found that looking at how the PSA level
      changes over time — rather than the level itself — may hold the key
      in determining who may be most at risk from prostate cancer.

      The finding is important because men with elevated PSA levels are
      faced with a difficult choice: "watchful waiting" or prostate-removal
      surgery that can cause impotence and incontinence. Some prostate
      tumors are so slow-growing that some, mostly older, patients may
      actually die of something else first.

      "It's not the static cutoff levels but the dynamic rate of change
      that'll help us get the tigers from the pussycats," said Dr. Donald
      Coffey, a researcher at Johns Hopkins Hospital.

      "This PSA is becoming a much more important tool when you look at it
      with the rate," Coffey said a conference last week in Niagara Falls,
      where researches noted the 25h anniversary and looked ahead to future
      research.

      Prostate cancer is the most common cancer in America, according to
      the Prostate Cancer Foundation, which estimates that more than
      232,000 men will be diagnosed this year and 30,000 men will die from
      it.

      Among high-profile survivors are New York City Mayor Rudy Giuliani,
      Yankees manager Joe Torre and former U.S. Sen. Bob Dole.

      http://news.yahoo.com/s/ap/prostate_test_25th;_ylt=AuUhyYSL3xgLGMZwWTc
      ZQXADW7oF;_ylu=X3oDMTBiMW04NW9mBHNlYwMlJVRPUCUl
    Your message has been successfully submitted and would be delivered to recipients shortly.